Interleukin 2 treatment in HIV-1 infection

Lancet

Volumn 367, Issue 9516, 2006, Pages 1054-1055

  Angus, Brian ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; ANTINEOPLASTIC AGENT; INFLUENZA VACCINE;

CLINICAL TRIAL; DRUG EFFECT; DRUG MECHANISM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLUENZA VACCINATION; LETTER; PRIORITY JOURNAL; NOTE; TIME;

ANTINEOPLASTIC AGENTS; CLINICAL TRIALS; HIV INFECTIONS; HIV-1; HUMANS; INFLUENZA VACCINES; INTERLEUKIN-2; TIME FACTORS;

EID: 33645752076     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(06)68467-5     Document Type: Letter

References (1)

1. Vento S., Cainelli F., and Temesgen Z. Interleukin-2 therapy and CD4+ T cells in HIV-infection. Lancet 367 (2006) 93-95